199 related articles for article (PubMed ID: 29752954)
1. Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.
Perakakis N; Upadhyay J; Ghaly W; Chen J; Chrysafi P; Anastasilakis AD; Mantzoros CS
Metabolism; 2018 Aug; 85():240-249. PubMed ID: 29752954
[TBL] [Abstract][Full Text] [Related]
2. Circulating profile of Activin-Follistatin-Inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment.
Bouzoni E; Perakakis N; Mantzoros CS
Metabolism; 2020 Dec; 113():154392. PubMed ID: 33045195
[TBL] [Abstract][Full Text] [Related]
3. Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner.
Moragianni VA; Aronis KN; Chamberland JP; Mantzoros CS
J Clin Endocrinol Metab; 2011 Dec; 96(12):3750-8. PubMed ID: 21917874
[TBL] [Abstract][Full Text] [Related]
4. Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males.
Vamvini MT; Aronis KN; Chamberland JP; Mantzoros CS
J Clin Endocrinol Metab; 2011 Nov; 96(11):3416-23. PubMed ID: 21865351
[TBL] [Abstract][Full Text] [Related]
5. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study.
Anastasilakis AD; Polyzos SA; Rodopaios NE; Makras P; Kumar A; Kalra B; Mantzoros CS
Metabolism; 2023 Apr; 141():155397. PubMed ID: 36587801
[TBL] [Abstract][Full Text] [Related]
6. Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise.
Perakakis N; Mougios V; Fatouros I; Siopi A; Draganidis D; Peradze N; Ghaly W; Mantzoros CS
J Clin Endocrinol Metab; 2018 Oct; 103(10):3890-3899. PubMed ID: 30085147
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of the components of the GH/IGF-1/IGFBPs axis total and intact IGF-binding proteins (IGFBP) 3 and IGFBP 4 and total IGFBP 5, as well as PAPPA, PAPPA2 and Stanniocalcin-2 levels are not altered in response to energy deprivation and/or metreleptin administration in humans.
Pilitsi E; Peradze N; Perakakis N; Mantzoros CS
Metabolism; 2019 Aug; 97():32-39. PubMed ID: 31103608
[TBL] [Abstract][Full Text] [Related]
8. Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women.
Brinkoetter M; Magkos F; Vamvini M; Mantzoros CS
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E99-E104. PubMed ID: 21505147
[TBL] [Abstract][Full Text] [Related]
9. Preadipocyte factor-1 levels are higher in women with hypothalamic amenorrhea and are associated with bone mineral content and bone mineral density through a mechanism independent of leptin.
Aronis KN; Kilim H; Chamberland JP; Breggia A; Rosen C; Mantzoros CS
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1634-9. PubMed ID: 21795455
[TBL] [Abstract][Full Text] [Related]
10. Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study.
Anastasilakis AD; Polyzos SA; Savvidis M; Anastasilakis DA; Sarridimitriou A; Kumar A; Kalra B; Makras P; Mantzoros CS
Endocrine; 2023 Sep; 81(3):573-578. PubMed ID: 37221430
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.
Refaat B; Ashshi AM; El-Shemi AG; AlZanbagi A
Clin Exp Med; 2015 Aug; 15(3):293-302. PubMed ID: 24925642
[TBL] [Abstract][Full Text] [Related]
12. Roles of inhibins, activins, and follistatin in the female reproductive system.
Knight PG
Front Neuroendocrinol; 1996 Oct; 17(4):476-509. PubMed ID: 8905350
[TBL] [Abstract][Full Text] [Related]
13. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study.
Panagiotou G; Papakonstantinou E; Vagionas A; Polyzos SA; Mantzoros CS
J Clin Endocrinol Metab; 2019 Feb; 104(2):349-358. PubMed ID: 30388235
[TBL] [Abstract][Full Text] [Related]
14. Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin.
Bilezikjian LM; Blount AL; Leal AM; Donaldson CJ; Fischer WH; Vale WW
Mol Cell Endocrinol; 2004 Oct; 225(1-2):29-36. PubMed ID: 15451565
[TBL] [Abstract][Full Text] [Related]
15. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors.
Bilezikjian LM; Corrigan AZ; Blount AL; Vale WW
Endocrinology; 1996 Oct; 137(10):4277-84. PubMed ID: 8828487
[TBL] [Abstract][Full Text] [Related]
16. Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes.
Sylow L; Vind BF; Kruse R; Møller PM; Wojtaszewski JFP; Richter EA; Højlund K
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112102
[TBL] [Abstract][Full Text] [Related]
17. Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans.
Kang ES; Magkos F; Sienkiewicz E; Mantzoros CS
Eur J Endocrinol; 2011 Jun; 164(6):911-7. PubMed ID: 21422197
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta regulates pituitary follistatin and inhibin/activin betaB mRNA levels and attenuates FSH secretion in response to activin-A.
Bilezikjian LM; Turnbull AV; Corrigan AZ; Blount AL; Rivier CL; Vale WW
Endocrinology; 1998 Jul; 139(7):3361-4. PubMed ID: 9645713
[TBL] [Abstract][Full Text] [Related]
19. Serum activin A and follistatin levels in gestational diabetes and the association of the Activin A-Follistatin system with anthropometric parameters in offspring.
Näf S; Escote X; Ballesteros M; Yañez RE; Simón-Muela I; Gil P; Albaiges G; Vendrell J; Megia A
PLoS One; 2014; 9(4):e92175. PubMed ID: 24763182
[TBL] [Abstract][Full Text] [Related]
20. Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.
Teede H; Ng S; Hedger M; Moran L
Metabolism; 2013 Oct; 62(10):1394-400. PubMed ID: 23768911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
